- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
4105
TWO
Week ended 14 Aug 2026
Weekly Investor Report
TTY Biopharm Company Limited · Healthcare · Drug Manufacturers - Specialty & Generic
Latest close
76.10 TWD
-0.5%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -0.1% below the Trend Line and sits at 46.5% of its 52-week range. The latest completed week returned -0.5%, after a -2.2% four-week move. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.
Setup score
40
out of 100
Latest Close
76.10 TWD
14 Aug 2026
1W Return
-0.5%
latest completed week
4W Return
-2.2%
short-term follow-through
12W Return
2.7%
quarterly tape
Trend Breadth
59.6%
31 of 52 weeks active
Volume Ratio
0.6x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Activity pressure is weak, so confirmation is not yet broad enough.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-0.5%
Latest completed week; four-week move -2.2%.
Indicator stack
33/54
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
50/100
0 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -0.1% below the Trend Line and sits at 46.5% of its 52-week range. The latest completed week returned -0.5%, after a -2.2% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.6x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
14 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.3812-week average 0.21
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure7/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.38Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -2.2% over four weeks, 2.7% over 12 weeks, and 6.4% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year31
Trend breadth59.6%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.40Latest activity-pressure read.
Pressure change-45.4%Four-week change in activity pressure.
Leadership-28.78Latest relative-leadership reading.
RS change-14.5%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 0 relevant articles.
0 positive · 0 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-7.3%Distance below the 52-week high.
13-week volatility2.1%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
20 Mar
17 Apr
15 May
12 Jun
10 Jul
14 Aug
Weeks higher10 of 2616 weeks finished lower.
Best week+4.4%Week of 3 Jul.
Worst week-3.4%Week of 31 Jul.
Latest week-0.5%Week of 14 Aug.
Shape of recent returns
Strong gains1
Modest gains9
Flat weeks0
Modest losses16
Sharp losses0
Recent vol2.1%13-week weekly-return volatility.
Base vol1.8%52-week weekly-return volatility.
Up/down split25/26Count of positive and negative weeks in the 52-week window.
Average skew1.7% / -1.3%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorTW Healthcare
4-week rank67 / 100
Group average0.1%
Trend breadth34.0%
Trend34.0%active weekly trend signals
MD60.0%positive activity pressure
RS9.0%positive relative leadership
Four-week leaders
IndustryTW Drug Manufacturers - Specialty & Generic
4-week rank25 / 42
Group average-0.1%
Trend breadth21.4%
Trend21.4%active weekly trend signals
MD45.2%positive activity pressure
RS4.8%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape38/100
Trend, activity pressure, participation, and risk combine to a 38/100 tape read.
Indicator analysis28/100Latest 12-week confirmation: trend 0/12, activity pressure 7/12, relative leadership 0/12.
Activity pressure 0.38; No reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 0 relevant articles.
Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 14 Aug 2026 | 76.10 TWD | -0.5% | 76.14 TWD | 70.80 TWD | 0.40 | -28.78 | 2.8M | Off |
| 7 Aug 2026 | 76.50 TWD | 2.8% | 76.20 TWD | 70.73 TWD | 0.61 | -26.64 | 3.2M | Off |
| 31 Jul 2026 | 74.40 TWD | -3.4% | 76.19 TWD | 70.66 TWD | 0.71 | -27.63 | 4.8M | Off |
| 24 Jul 2026 | 77.00 TWD | -1.0% | 76.31 TWD | 70.62 TWD | 0.93 | -26.83 | 5.8M | Off |
| 17 Jul 2026 | 77.80 TWD | 0.6% | 76.39 TWD | 70.55 TWD | 0.73 | -25.13 | 5.1M | Off |
| 10 Jul 2026 | 77.30 TWD | -0.8% | 76.38 TWD | 70.48 TWD | 0.37 | -30.72 | 3.4M | Off |
| 3 Jul 2026 | 77.90 TWD | 4.4% | 76.42 TWD | 70.41 TWD | 0.11 | -33.08 | 6.8M | Off |
| 26 Jun 2026 | 74.60 TWD | 1.5% | 76.39 TWD | 70.33 TWD | -0.17 | -33.51 | 3.7M | Off |
| 19 Jun 2026 | 73.50 TWD | -0.8% | 76.37 TWD | 70.27 TWD | -0.46 | -37.90 | 2.9M | Off |
| 12 Jun 2026 | 74.10 TWD | -1.9% | 76.40 TWD | 70.22 TWD | -0.62 | -35.00 | 4.9M | Off |
| 5 Jun 2026 | 75.50 TWD | 2.9% | 76.43 TWD | 70.15 TWD | -0.78 | -35.90 | 7.9M | Off |
| 29 May 2026 | 73.40 TWD | -0.9% | 76.41 TWD | 70.08 TWD | -0.97 | -37.96 | 3.4M | Off |
| 22 May 2026 | 74.10 TWD | -1.3% | 76.53 TWD | 70.02 TWD | -1.01 | -34.50 | 2.5M | Off |
| 15 May 2026 | 75.10 TWD | -0.4% | 76.62 TWD | 69.96 TWD | -0.99 | -32.57 | 3.0M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.